Khaniukov O. O., Sapozhnychenko L. V., Smolyanova O. V., Kovtun O. V., Doroshenko A. M.


About the author:

Khaniukov O. O., Sapozhnychenko L. V., Smolyanova O. V., Kovtun O. V., Doroshenko A. M.



Type of article:

Scentific article


The aim of the work is to assess the functional condition of the kidneys in patients with chronic heart failure (CHF) of ischemic etiology and liver steatosis. Object and methods. 66 patients with CHF were examined, the main etiological factor of which were ischemic heart disease and arterial hypertension. The diagnosis of heart failure was established on the basis on the level of the N-terminal Brain pro-natriuretic peptide and echocardiography with determination of the ejection fraction (EF) of the left ventricle (LV). The severity of the clinical condition of CHF and the functional status of the patient were assessed. All patients underwent clinical and biochemical sampling, electrocardiography, ultrasound of the liver. The glomerular filtration rate (GFR) was calculated using the MDRD formula and the stage of chronic kidney disease (CKD) was determined; NAFLD Fibrosis SCORE (NFS) was used to assess the presence of liver fibrosis. Results. It was found that the majority of patients (45.5%) had 2 stage of CKD, 7 (10.6%) – stage 1, 15 (22.7%) – 3a and 12 (21.2%) – 3b. Mean GFR was 62.9±18.3 ml/min/1.73 m². According to NFS data, 21.2% of patients with CHF had a high probability of liver fibrosis (F3-F4), 57.6% had an intermediate value and 21.2% did not have severe fibrosis (F0-F2). All patients had ultrasonic signs of liver steatosis. NYHA I functional class (FC) was present in 10 patients, NYHA II – in 25 patients, NYHA III – in 31 patients. It was found that with an increase in the scores on the SCAHF and FC of NYHA, GFR decreases and the stage of CKD increases (p<0.001). In the correlation analysis was obtained a direct relationship between GFR and LVEF (r = 0.27; p <0.05). It was found that while increasing NFS GFR decrease (r = -0.46; p <0.001) and the CKD stage increases (r = 0.50; p <0.001). Conclusions. Shown that with increasing scores for the SCAHF, FC CHF, an indicator of the possibility of liver fibrosis NFS, GFR decreases (r = -0.46; p <0.001) and the stage of CKD increases (r = 0.50; p <0.001). Early finding of renal involvement in patients with heart failure and non-alcoholic fatty liver disease would help to select patients for more thorough follow-up and the selection of optimal therapy.


chronic heart failure, chronic kidney disease, liver steatosis, NAFLD Fibrosis SCORE.


  1. Peter M Engelfriet, Rudolf T Hoogenveen, Hendriek C Boshuizen, Pieter HM van Baal. To die with of from heart failure: a difference that counts: is heart failure underrepresented in national mortality statistics? Eur J Heart Fail. 2011;13:37-8. DOI: 10.1093/eurjhf/hfq223
  2. Kenji Miyagishima, Shinya Hiramitsu, Hisashi Kimura, Kazumasa Mori, Tomoya Ueda, Shigeru Kato, et al. Long term prognosis of chronic heart failure: reduced vs preserved left ventricular ejection fraction. Circulation. 2009;73(1):92-9. DOI: 10.1253/circj.cj-07-1016
  3. Hwang ST, Cho YK, Yun JW. Impact of non-alcoholic fatty liver disease on microalbuminuria in patients with prediabetes and diabetes. Internal Medicine J. 2010;40(6):437-42. DOI: 10.1111/j.1445-5994.2009.01979.x
  4. Giovanni Targher, Lorenzo Bertolini, Stefano Rodella, Giuseppe Lippi, Giacomo Zoppini, Michel Chonchol. Relationship between kidney function and liver histology in subjects with nonalcoholic steatohepatitis. Clin J Am Soc Nephrol. 2010;5(12):2166-71. DOI: 10.2215/ CJN.05050610
  5. Pamela S. Douglas, Blase A. Carabello, Roberto M. Lang, Leo Lopez, Patricia A. Pellikka, Michael H. Picard, et al. 2019 ACC/AHA/ASE Key Data Elements and Definitions for Transthoracic Echocardiography: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Clinical Data Standards for Transthoracic Echocardiography) and the American Society of Echocardiography 24 Jun 2019 Circulation: Cardiovascular Imaging. 2019;12:e000027. DOI: doi. org/10.1161/HCI.0000000000000027
  6. NAFLD (Non-Alcoholic Fatty Liver Disease) Fibrosis Score. Available from:
  7. Paul Angulo 1, Jason M Hui, Giulio Marchesini, Ellisabetta Bugianesi, Jacob George, Geoffrey C Farrell, et al. The NAFLD Fibrosis Score: A Noninvasive System That Identifies Liver Fibrosis in Patients with NAFLD. Hepatology. 2007;4(45):846-54. Available from: https://doi. org/10.1002/hep.21496
  8. Yu Sato, Akiomi Yoshihisa, Shunsuke Watanabe, Tetsuro Yokokawa, Shunsuke Miura, Takamasa Sato, et al. Liver Fibrosis Score Predicts Mortality in Heart Failure Patients With Preserved Ejection Fraction. Originally published 29 Mar 2018. Circulation. 2016;134:A11590. DOI: 10.1002/ehf2.12222
  9. Mitja Lainscak, Lea Hodoscek-Majc, Dejan Majc, Rozentryt Piotr, Jochen Springer, Wolfram Doehner, et al. Liver Function Markers and Mortality in Patients with Chronic Heart Failure. 22 Mar 2018 Circulation. 2008;118:616.
  10. Zhe Shen, Stefan Munker, Fugang Luo, Han Ma, Chaohui Yu, Youming Li. Effect of Non-Alcoholic Fatty Liver Disease on Estimated Glomerular Filtration Rate Could Be Dependent on Age. PLoS One. 2015 Jun 18;10(6):e0130614. DOI: 10.1371/journal.pone.0130614

Publication of the article:

«Bulletin of problems biology and medicine» Issue 2 (156), 2020 year, 174-178 pages, index UDK 616.12-005.4-008.46-036.1+616.36-003.826:616.61-008.6-07